Variant report

Variant	nsv456788
Chromosome Location	chr15:33900705-33909822
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr15:33601747..33602901-chr15:33900633..33901527,4	MCF-7	breast:
2	chr15:33904850..33906861-chr15:33932211..33933758,2	MCF-7	breast:
3	chr15:33902112..33903948-chr15:33926108..33928940,2	K562	blood:

Variant related genes	Relation type
ENSG00000259446	chromatin interactions

Extended variants
information (count: 399 )
Associated
traits (count: 66 )

Variant overlapped rSNPs/rCNVs (count:399 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs8034012	chr15:33900705-33900706	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs552356976	chr15:33900719-33900720	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs570960581	chr15:33900724-33900725	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs150451583	chr15:33900727-33900728	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs138227156	chr15:33900728-33900729	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs568652239	chr15:33900768-33900769	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs536119028	chr15:33900862-33900863	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs115292471	chr15:33900905-33900906	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs142831943	chr15:33900914-33900915	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs567464076	chr15:33900948-33900949	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs377198820	chr15:33900982-33900983	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs371946364	chr15:33901008-33901009	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs369048215	chr15:33901028-33901029	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs540051048	chr15:33901060-33901061	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs376869818	chr15:33901081-33901082	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs16973242	chr15:33901103-33901104	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs576898333	chr15:33901113-33901114	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs76759468	chr15:33901121-33901122	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs376547090	chr15:33901126-33901127	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs189903427	chr15:33901202-33901203	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs146060669	chr15:33901207-33901208	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs574104279	chr15:33901219-33901220	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs533619138	chr15:33901263-33901264	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs550154249	chr15:33901330-33901331	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs138791142	chr15:33901421-33901422	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs527469861	chr15:33901440-33901441	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs546009849	chr15:33901452-33901453	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs571523973	chr15:33901495-33901496	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs56391517	chr15:33901499-33901500	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs181756111	chr15:33901517-33901518	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs35129808	chr15:33901521-33901522	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs568415230	chr15:33901524-33901525	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs141947886	chr15:33901529-33901530	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs1495287	chr15:33901534-33901535	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs566409561	chr15:33901536-33901537	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs539622216	chr15:33901546-33901547	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs558376653	chr15:33901557-33901558	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs373503926	chr15:33901618-33901619	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs537905353	chr15:33901619-33901620	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs556006991	chr15:33901623-33901624	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs574061328	chr15:33901634-33901635	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs541459643	chr15:33901673-33901674	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs141280533	chr15:33901680-33901681	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs377292651	chr15:33901692-33901693	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs572057664	chr15:33901704-33901705	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs545672003	chr15:33901728-33901729	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs150763065	chr15:33901812-33901813	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs185676996	chr15:33901815-33901816	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs543867108	chr15:33901874-33901875	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs555191740	chr15:33901951-33901952	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:66)

Disease	PMID	Source
HDAC8	0	CNVD
NIPBL	0	CNVD
RAD21	0	CNVD
SMC1A	0	CNVD
SMC3	0	CNVD
Ewing''s sarcoma	21437220	CNVD
Schizophrenia	19415332	CNVD
Breast cancer	22522925	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Angelman syndrome	16183798	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Testicular germ cell tumor	18059402	CNVD
cataract	16735990	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Medulloblastoma	21979893	CNVD
spastic paraplegia with thinning of corpus callosum	19105190	CNVD
Schizophrenia	21324950	CNVD
Astrocytoma	17387387	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Disease	21824424	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Melanoma	18172304	CNVD
Colorectal cancer	16774939	CNVD
Gastric cancer	17167181	CNVD
Neuroblastoma	19435921	CNVD
Colorectal cancer	19359472	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Colorectal cancer	16272173	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Multiple myeloma	17550852	CNVD
Intellectual disability	22102821	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Prostate cancer	16573809	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Multiple myeloma	20724749	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	21785460	CNVD
Abnormal corpus callosum	21572526	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Autism	19204725	CNVD
Schizophrenia	19204725	CNVD
Schizophrenia	19149910	CNVD
Ovarian cancer	22174824	CNVD
Prostate cancer	18632612	CNVD
small cell lung cancer	20016488	CNVD
Legius syndrome	19443465	CNVD
Holoprosencephaly	21359414	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Prader-willi syndrome	21504564	CNVD
Cancer	17440070	CNVD
Basal cell lymphoma	17053054	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD

Chromatin state (count:33 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr15:33858000-33921200	Weak transcription	Stomach Smooth Muscle	stomach
2	chr15:33859200-33923200	Weak transcription	Fetal Muscle Trunk	muscle
3	chr15:33873000-33923400	Weak transcription	Brain Anterior Caudate	brain
4	chr15:33891800-33921800	Weak transcription	Skeletal Muscle Male	skeletal muscle
5	chr15:33892800-33904200	Weak transcription	Fetal Stomach	stomach
6	chr15:33893800-33905200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
7	chr15:33893800-33911800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
8	chr15:33895600-33922800	Weak transcription	Aorta	Aorta
9	chr15:33897600-33915800	Weak transcription	Fetal Muscle Leg	muscle
10	chr15:33897600-33919600	Weak transcription	Breast Myoepithelial Primary Cells	Breast
11	chr15:33900600-33900800	Enhancers	ES-WA7 Cell Line	embryonic stem cell
12	chr15:33900600-33901800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
13	chr15:33901800-33905000	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
14	chr15:33904800-33905000	Enhancers	HUES6 Cell Line	embryonic stem cell
15	chr15:33904800-33905200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
16	chr15:33904800-33905400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
17	chr15:33904800-33905400	Bivalent Enhancer	HSMMtube	muscle
18	chr15:33905000-33905200	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
19	chr15:33905000-33905400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
20	chr15:33905000-33905400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
21	chr15:33905000-33905400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
22	chr15:33905000-33905400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
23	chr15:33905000-33905800	Enhancers	ES-I3 Cell Line	embryonic stem cell
24	chr15:33905200-33905600	Enhancers	H1 Cell Line	embryonic stem cell
25	chr15:33905200-33905600	Enhancers	HUES6 Cell Line	embryonic stem cell
26	chr15:33905200-33905600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
27	chr15:33905200-33905800	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
28	chr15:33905400-33905600	Flanking Bivalent TSS/Enh	HSMMtube	muscle
29	chr15:33905400-33905800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
30	chr15:33905400-33908600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
31	chr15:33905600-33915200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
32	chr15:33908600-33909000	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood
33	chr15:33908600-33909200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links